IDEX Kicks off Tomorrow in Abu Dhabi
BU DHABI, United Arab Emirates - Saturday, February 21st 2015 [ME NewsWire]
The Traffic and Patrols Directorate at Abu Dhabi Police announced that traffic movement will be shifted near Abu Dhabi National Exhibition Center (ADNEC) area. The road will be closed in both directions on Khaleej Al Arabi tomorrow, Sunday February 22. Motorists have been urged to find alternative routes for the International Defense Exhibition and Conference (IDEX 2015) being held at Abu Dhabi National Exhibition Centre, which runs from February 22 to 26 .
The Traffic and Patrols Directorate announced that traffic will temporarily be shifted along Khaleej Al Arabi Street and the routes leading up to ADNEC from 10:00 to midday on Sunday. The road will be closed in both directions on Khaleej Al Arabi Street and stretches as follows: from Saeed bin Tahnoon intersection towards the new bridges heading out of Abu Dhabi; streets leading up to ADNEC to Sheikh Suroor Bridge heading into Abu Dhabi; from Al Noor Hospital roundabout towards Khaleej Al Arabi street; and from Sheikh Rashid bin Saeed Street towards ADNEC.
The Traffic and Patrols Directorate called upon motorists to find alternative routes, adhere to traffic instructions and regulations, to exercise caution, and reduce speeds to avoid traffic accidents.
It is worth mentioning that the Security Media Department at the General Secretariat of the Office of H.H Deputy Prime Minister & Minister of Interior has published a map containing details on the closed streets and alternative routes designated for the public. The map can be viewed on the MoI’s social media accounts on:
Facebook - https://www.facebook.com/AbuDhabiPolice
Twitter - @AbuDhabiPolice
Instagram - moiuae
Google+ - https://plus.google.com/111953851120413906365
YouTube - http://www.youtube.com/user/theabudhabipolice
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Permalink: http://me-newswire.net/news/13720/en
Thursday, February 26, 2015
ASQ World Conference to Inspire Attendees, Provide Them with Innovation, Leadership Tools
DonorsChoose.org CEO, popular positive psychology researcher among keynote speakers at annual event
MILWAUKEE - Wednesday, February 25th 2015 [ME NewsWire]
(BUSINESS WIRE)-- Max India Limited’s Founder and Chair, Analjit Singh, is one of five keynote speakers who will present at ASQ’s 2015 World Conference on Quality and Improvement.
The ASQ conference — held May 4–6 at Gaylord Opryland Resort & Convention Center in Nashville, Tenn. — will provide attendees opportunities for career development, benchmarking, expert advice and tips, strategies, and best practices that can make an immediate business impact in their organizations.
The theme, “Transforming the World Through Innovation, Inspiration, and Leadership,” will focus on, among other areas, the intersection of quality and creativity, creating and sustaining a culture of quality, the risk of change, quality fundamentals, and globalization and the quality industry.
In addition to Singh, other keynote speakers include Shawn Achor, New York Times best-selling author and positive psychology researcher; JoAnn Sternke, Ed.D., superintendent, Pewaukee (Wis.) School District; Margaret Heffernan, entrepreneur, chief executive and author; and Charles Best, founder and CEO of DonorsChoose.org.
The World Conference on Quality and Improvement will feature more than 100 educational sessions covering topics critical to a variety of industries including manufacturing, health care, government, financial services and more.
ASQ certification exams also will be offered onsite, and ASQ will present the 2014-2015 International Team Excellence Awards, the only international team recognition process of its kind. Finalists will present their successes at Global Impact Sessions, which offer attendees the opportunity to learn first-hand from organizations that have used quality processes to save millions while delivering value to customers and stakeholders.
To register or learn more about WCQI, visit wcqi.asq.org/index.html.
About ASQ
ASQ is a global community of people dedicated to quality who share the ideas and tools that make our world work better. With millions of individual and organizational members of the community in 150 countries, ASQ has the reputation and reach to bring together the diverse quality champions who are transforming the world’s corporations, organizations and communities to meet tomorrow’s critical challenges. ASQ is headquartered in Milwaukee, Wisconsin, with national service centers in China, India, Mexico and a regional service center in the United Arab Emirates. Learn more about ASQ’s members, mission, technologies and training at asq.org.
Contacts
ASQ
Kevin Braley
(414) 272-8575 ext. 7587
(800) 248-1946
kbraley@asq.org
Permalink: http://me-newswire.net/news/13755/en
MILWAUKEE - Wednesday, February 25th 2015 [ME NewsWire]
(BUSINESS WIRE)-- Max India Limited’s Founder and Chair, Analjit Singh, is one of five keynote speakers who will present at ASQ’s 2015 World Conference on Quality and Improvement.
The ASQ conference — held May 4–6 at Gaylord Opryland Resort & Convention Center in Nashville, Tenn. — will provide attendees opportunities for career development, benchmarking, expert advice and tips, strategies, and best practices that can make an immediate business impact in their organizations.
The theme, “Transforming the World Through Innovation, Inspiration, and Leadership,” will focus on, among other areas, the intersection of quality and creativity, creating and sustaining a culture of quality, the risk of change, quality fundamentals, and globalization and the quality industry.
In addition to Singh, other keynote speakers include Shawn Achor, New York Times best-selling author and positive psychology researcher; JoAnn Sternke, Ed.D., superintendent, Pewaukee (Wis.) School District; Margaret Heffernan, entrepreneur, chief executive and author; and Charles Best, founder and CEO of DonorsChoose.org.
The World Conference on Quality and Improvement will feature more than 100 educational sessions covering topics critical to a variety of industries including manufacturing, health care, government, financial services and more.
ASQ certification exams also will be offered onsite, and ASQ will present the 2014-2015 International Team Excellence Awards, the only international team recognition process of its kind. Finalists will present their successes at Global Impact Sessions, which offer attendees the opportunity to learn first-hand from organizations that have used quality processes to save millions while delivering value to customers and stakeholders.
To register or learn more about WCQI, visit wcqi.asq.org/index.html.
About ASQ
ASQ is a global community of people dedicated to quality who share the ideas and tools that make our world work better. With millions of individual and organizational members of the community in 150 countries, ASQ has the reputation and reach to bring together the diverse quality champions who are transforming the world’s corporations, organizations and communities to meet tomorrow’s critical challenges. ASQ is headquartered in Milwaukee, Wisconsin, with national service centers in China, India, Mexico and a regional service center in the United Arab Emirates. Learn more about ASQ’s members, mission, technologies and training at asq.org.
Contacts
ASQ
Kevin Braley
(414) 272-8575 ext. 7587
(800) 248-1946
kbraley@asq.org
Permalink: http://me-newswire.net/news/13755/en
Gore Global Registry for Endovascular Aortic Treatment Reaches 2,500 Enrolled Patients
Milestone Achievement in Monitoring Patient Outcomes and Device Performance
FLAGSTAFF, Ariz - Wednesday, February 25th 2015 [ME NewsWire]
(BUSINESS WIRE) -- W. L. Gore & Associates, Inc. (Gore) reports that more than 2,500 patients have been enrolled in the Gore Global Registry for Endovascular Aortic Treatment (GREAT). The registry is part of Gore’s dedication to post-market surveillance and monitoring long-term device performance in an effort to improve clinical practice and patient outcomes. Since August 2010, GREAT has collected data on patients treated with the minimally invasive GORE® TAG® Thoracic Endoprosthesis, Conformable GORE® TAG® Thoracic Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis featuring C3® Delivery System and most recently, the GORE® EXCLUDER® Iliac Branch Endoprosthesis. A total of 5,000 consecutive patients from up to 300 worldwide sites will be enrolled in the registry and their treatment results will be tracked for 10 years.
“What separates the Gore registry from other medical registries is the minimal exclusion criteria, unprecedented number of patients, and length of follow-up,” said Ross Milner, MD, Professor of Surgery, Co-Director, Center for Aortic Diseases, and Associate Program Director, Vascular Surgery Fellowship at the University of Chicago Medical Center. “The active tracking of long-term device performance and associated patient outcomes will provide key insights into real-world clinical practice, which is vital to advancing the future of endovascular repair and improving patient outcomes.”
GREAT is currently comprised of 2,511 patients at 84 sites in 13 countries and demonstrates the proven performance of the Gore product portfolio. The registry tracks outcomes during patient treatment and post-treatment visits for up to 10 years, providing longer-term follow-up than past prospective registries. In addition to procedural and clinical outcomes, data collected include device used, treatment indication, patient demographics, and medical history.
“GREAT demonstrates the collaborative dedication of physicians around the world to advance patient care,” said Piergiorgio Cao, MD, Chief of Vascular Surgery at San Camillo Forlanini Hospital, Rome, Italy. “We want to ensure that patients are receiving optimal treatment through safe therapies.”
To date, 80% of the GREAT procedures have been EVAR, 16% TEVAR, and 4% were other endovascular procedures. The most commonly treated pathologies have been abdominal aortic aneurysm (72%), iliac aneurysms (10%), descending thoracic aortic aneurysms (7%), and Type B dissections (3%).
GREAT investigators have consistently shared registry results through publication and presentations at professional and society meetings. The latest registry findings and outcomes will be presented at the 2015 Charing Cross International Symposium in April and Vascular Annual Meeting in June.
“GREAT exemplifies our dedication to advancing endovascular therapy and providing durable products for patients worldwide. Creating a collaborative environment for physicians to come together is a cornerstone of our commitment at Gore Medical,” said Ryan Takeuchi, Gore Aortic Business Leader.
ABOUT US
At Gore, we have provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the US “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.
GORE®, TAG®, and EXCLUDER® are trademarks of W. L. Gore & Associates.
Contacts
Chempetitive Group for W. L. Gore & Associates
Kena Hudson or Patrick French,
510-908-0966
GoreMedical@Chempetitive.com
Permalink: http://me-newswire.net/news/13764/en
FLAGSTAFF, Ariz - Wednesday, February 25th 2015 [ME NewsWire]
(BUSINESS WIRE) -- W. L. Gore & Associates, Inc. (Gore) reports that more than 2,500 patients have been enrolled in the Gore Global Registry for Endovascular Aortic Treatment (GREAT). The registry is part of Gore’s dedication to post-market surveillance and monitoring long-term device performance in an effort to improve clinical practice and patient outcomes. Since August 2010, GREAT has collected data on patients treated with the minimally invasive GORE® TAG® Thoracic Endoprosthesis, Conformable GORE® TAG® Thoracic Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis featuring C3® Delivery System and most recently, the GORE® EXCLUDER® Iliac Branch Endoprosthesis. A total of 5,000 consecutive patients from up to 300 worldwide sites will be enrolled in the registry and their treatment results will be tracked for 10 years.
“What separates the Gore registry from other medical registries is the minimal exclusion criteria, unprecedented number of patients, and length of follow-up,” said Ross Milner, MD, Professor of Surgery, Co-Director, Center for Aortic Diseases, and Associate Program Director, Vascular Surgery Fellowship at the University of Chicago Medical Center. “The active tracking of long-term device performance and associated patient outcomes will provide key insights into real-world clinical practice, which is vital to advancing the future of endovascular repair and improving patient outcomes.”
GREAT is currently comprised of 2,511 patients at 84 sites in 13 countries and demonstrates the proven performance of the Gore product portfolio. The registry tracks outcomes during patient treatment and post-treatment visits for up to 10 years, providing longer-term follow-up than past prospective registries. In addition to procedural and clinical outcomes, data collected include device used, treatment indication, patient demographics, and medical history.
“GREAT demonstrates the collaborative dedication of physicians around the world to advance patient care,” said Piergiorgio Cao, MD, Chief of Vascular Surgery at San Camillo Forlanini Hospital, Rome, Italy. “We want to ensure that patients are receiving optimal treatment through safe therapies.”
To date, 80% of the GREAT procedures have been EVAR, 16% TEVAR, and 4% were other endovascular procedures. The most commonly treated pathologies have been abdominal aortic aneurysm (72%), iliac aneurysms (10%), descending thoracic aortic aneurysms (7%), and Type B dissections (3%).
GREAT investigators have consistently shared registry results through publication and presentations at professional and society meetings. The latest registry findings and outcomes will be presented at the 2015 Charing Cross International Symposium in April and Vascular Annual Meeting in June.
“GREAT exemplifies our dedication to advancing endovascular therapy and providing durable products for patients worldwide. Creating a collaborative environment for physicians to come together is a cornerstone of our commitment at Gore Medical,” said Ryan Takeuchi, Gore Aortic Business Leader.
ABOUT US
At Gore, we have provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the US “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.
GORE®, TAG®, and EXCLUDER® are trademarks of W. L. Gore & Associates.
Contacts
Chempetitive Group for W. L. Gore & Associates
Kena Hudson or Patrick French,
510-908-0966
GoreMedical@Chempetitive.com
Permalink: http://me-newswire.net/news/13764/en
Saif bin Zayed Inaugurates NAVDEX 2015
Abu Dhabi, United Arab Emirates - Sunday, February 22nd 2015 [ME NewsWire]
Under the patronage of His Highness Sheikh Khalifa bin Zayed Al Nahyan, President of the UAE; Lt. General HH Sheikh Saif bin Zayed Al Nahyan, Deputy Prime Minister and Minister of Interior, inaugurated NAVDEX 2015, the international naval defense exhibition, on Sunday. The exhibition, organized on the pier opposite the main platform of the Abu Dhabi National Exhibition Centre (ADNEC), is part of the International Defense Exhibition (IDEX 2015).
H.H Sheikh Saif toured the pavilions of the national and international companies participating in this year’s IDEX and NAVDEX, and conversed with the exhibitors.
H.H Sheikh Saif praised the interest and support of His Highness Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President, Prime Minister and Ruler of Dubai, and the ongoing support for the events of the exhibition bestowed by General HH Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces. He also indicated that IDEX has succeeded in becoming a world leader in the arena for international exhibitions, and has greatly contributed to the noble reputation of the UAE as one of the favored platforms amongst participating international companies.
He also asserted that IDEX 2015 and NAVDEX 2015, alongside other accompanying events, are prominently positioned on the map of international exhibitions organized by the UAE. IDEX and NAVDEX provide a distinctive platform for many national and international companies to increase their share of the global market through the ability to showcase their products and display their latest innovations to the world.
“Over the recent years, the UAE’s advanced infrastructure and geographical location have consolidated our position as a regional and global leader in the exhibition industry,” H.H Sheikh Saif said. “The UAE enjoys a strategic location that lies at the heart of the Middle East, where we are close to the African and South Asian markets, and strongly tied to the Far Eastern and European regions.”
A number of Navy Forces officers, Ministry of Interior officers, senior officials of interested parties, and guests attended the inauguration ceremony.
It is worth mentioning that the NAVDEX 2015 features the latest and most advanced technologies of naval defenses for warships, vessels, amphibious vehicles, and military equipment in addition to coastal security systems and maritime communication solutions.
Stakeholders have high expectations for NAVDEX 2015, as it represents an international platform that attracts the most contractors specialized in technologies and services of naval security and defense.
NAVDEX 2015 provides attendees with the opportunity to visit naval vessels and ships harbored at the pier in the ADNEC marina- which was specifically built for this purpose. Attendees will also be able to visit visiting naval vessels harbored at Zayed Port in Abu Dhabi – a comprehensive platform for showcasing the latest technologies and systems in naval defense. The Zayed Port is also a dedicated venue for networking between manufacturers and operators.
NAVDEX 2015 features a fixed platform in an internal show room, live performances and events, and visits to naval vessels and ships harbored at the pier on Arabian Gulf waters alongside ADNEC.
This year, the exhibition welcomes official delegations from various countries around the world, and hosts key naval vessels from sisterly and friendly countries, including: the United States, France, Italy, the United Kingdom, Saudi Arabia, and Pakistan.
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Permalink: http://me-newswire.net/news/13728/en
Under the patronage of His Highness Sheikh Khalifa bin Zayed Al Nahyan, President of the UAE; Lt. General HH Sheikh Saif bin Zayed Al Nahyan, Deputy Prime Minister and Minister of Interior, inaugurated NAVDEX 2015, the international naval defense exhibition, on Sunday. The exhibition, organized on the pier opposite the main platform of the Abu Dhabi National Exhibition Centre (ADNEC), is part of the International Defense Exhibition (IDEX 2015).
H.H Sheikh Saif toured the pavilions of the national and international companies participating in this year’s IDEX and NAVDEX, and conversed with the exhibitors.
H.H Sheikh Saif praised the interest and support of His Highness Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President, Prime Minister and Ruler of Dubai, and the ongoing support for the events of the exhibition bestowed by General HH Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces. He also indicated that IDEX has succeeded in becoming a world leader in the arena for international exhibitions, and has greatly contributed to the noble reputation of the UAE as one of the favored platforms amongst participating international companies.
He also asserted that IDEX 2015 and NAVDEX 2015, alongside other accompanying events, are prominently positioned on the map of international exhibitions organized by the UAE. IDEX and NAVDEX provide a distinctive platform for many national and international companies to increase their share of the global market through the ability to showcase their products and display their latest innovations to the world.
“Over the recent years, the UAE’s advanced infrastructure and geographical location have consolidated our position as a regional and global leader in the exhibition industry,” H.H Sheikh Saif said. “The UAE enjoys a strategic location that lies at the heart of the Middle East, where we are close to the African and South Asian markets, and strongly tied to the Far Eastern and European regions.”
A number of Navy Forces officers, Ministry of Interior officers, senior officials of interested parties, and guests attended the inauguration ceremony.
It is worth mentioning that the NAVDEX 2015 features the latest and most advanced technologies of naval defenses for warships, vessels, amphibious vehicles, and military equipment in addition to coastal security systems and maritime communication solutions.
Stakeholders have high expectations for NAVDEX 2015, as it represents an international platform that attracts the most contractors specialized in technologies and services of naval security and defense.
NAVDEX 2015 provides attendees with the opportunity to visit naval vessels and ships harbored at the pier in the ADNEC marina- which was specifically built for this purpose. Attendees will also be able to visit visiting naval vessels harbored at Zayed Port in Abu Dhabi – a comprehensive platform for showcasing the latest technologies and systems in naval defense. The Zayed Port is also a dedicated venue for networking between manufacturers and operators.
NAVDEX 2015 features a fixed platform in an internal show room, live performances and events, and visits to naval vessels and ships harbored at the pier on Arabian Gulf waters alongside ADNEC.
This year, the exhibition welcomes official delegations from various countries around the world, and hosts key naval vessels from sisterly and friendly countries, including: the United States, France, Italy, the United Kingdom, Saudi Arabia, and Pakistan.
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Permalink: http://me-newswire.net/news/13728/en
Quintiles Appoints Elgar Peerschke as President of Advisory Services
RESEARCH TRIANGLE PARK, N.C. - Wednesday, February 25th 2015 [ME NewsWire]
(BUSINESS WIRE) -- Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for leading Quintiles’ Advisory Services organization and the continued development and delivery of its related services.
Bringing more than 25 years of experience to Quintiles, Elgar joins Quintiles from Bain & Company, a global business consulting firm, where he was a senior partner in its Global Healthcare Practice Group and a leading client service partner. Prior to Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles.
“Throughout his career, Elgar has focused on the healthcare industry, providing cutting-edge insight and guidance in boardrooms of biopharmaceutical customers around the world,” said Tom Pike, chief executive officer, Quintiles. “His deep experience working on and developing innovative solutions for the biopharmaceutical industry combined with his extensive leadership expertise across a number of strategic and operational disciplines is a tremendous addition to an already strong Quintiles team.”
Peerschke said, “I am extremely excited to be joining Quintiles and leading its world-class Advisory Services organization. The biopharmaceutical landscape continues to evolve at an incredible pace that requires innovative thinking, diverse expertise and flawless execution. I believe Quintiles – with its full-range of services – is uniquely positioned to succeed in this environment, enabling the connection of insights and superior delivery that improves our customers’ probability of success.”
Peerschke earned his bachelor’s degree in political science from Rutgers University and his MBA from New York University.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top- 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Mari Mansfield, Media Relations (mari.mansfield@quintiles.com)
+1-919-998-2639
or
Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)
+1-919-998-2789
Permalink: http://me-newswire.net/news/13752/en
(BUSINESS WIRE) -- Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for leading Quintiles’ Advisory Services organization and the continued development and delivery of its related services.
Bringing more than 25 years of experience to Quintiles, Elgar joins Quintiles from Bain & Company, a global business consulting firm, where he was a senior partner in its Global Healthcare Practice Group and a leading client service partner. Prior to Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles.
“Throughout his career, Elgar has focused on the healthcare industry, providing cutting-edge insight and guidance in boardrooms of biopharmaceutical customers around the world,” said Tom Pike, chief executive officer, Quintiles. “His deep experience working on and developing innovative solutions for the biopharmaceutical industry combined with his extensive leadership expertise across a number of strategic and operational disciplines is a tremendous addition to an already strong Quintiles team.”
Peerschke said, “I am extremely excited to be joining Quintiles and leading its world-class Advisory Services organization. The biopharmaceutical landscape continues to evolve at an incredible pace that requires innovative thinking, diverse expertise and flawless execution. I believe Quintiles – with its full-range of services – is uniquely positioned to succeed in this environment, enabling the connection of insights and superior delivery that improves our customers’ probability of success.”
Peerschke earned his bachelor’s degree in political science from Rutgers University and his MBA from New York University.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top- 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Mari Mansfield, Media Relations (mari.mansfield@quintiles.com)
+1-919-998-2639
or
Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)
+1-919-998-2789
Permalink: http://me-newswire.net/news/13752/en
Yealink’s Launches New Gigabit Speed SIP-T29G VoIP Phone
Dubai, United Arab Emirates - Sunday, February 22nd 2015 [ME NewsWire]
Yealink, globally ranked as the world’s second largest SIP phone provider, have taken another firm step Leading the Gigabit-Ethernet technology revolution with the launch futuristic SIP T29G VoIP Phone. This latest business gadget boast of high-resolution TFT color display for an enriched visual experience while adding Yealink Optima HD voice technology to enable a rich, clear and 3D like voice communication experience through its HD handset and headset.
A successor of the SIP T28P, the SIP T29G builds on the performance of the latter catering to limited budget SME is looking to benefit from the fast speed and convenience of Gigabit Ethernet.
The T29G allows connectivity with multiple devices including EHS headset and USB and encapsulates productivity enhancement features of programmable keys, built-in USB port Bluetooth headset support and accessibility through its USB dongle. SIP T29G also supports expansion modules with a PoE support and enable ease in use by enabling up to 16 VoIP accounts to its users.
Maggie Liu, EMEA Sales Manager of Yealink says, “Yealink’s products are all based on progressive cutting-edge technology that meets rigorous test standards for quality, performance and the lowest-possible power consumption during standby, calls or 3-way conferencing. Our constant strive for excellence drives us to provide a better and refined experience for the end user.”
Sabu Thomas, Director of Channel Development at DVCOM Technology, the distributors of Yealink in the Middle East comments, “Yealink is a world leader in original research and product innovation. While accomplishing the base line solutions and keeping their users interest in the mind, they work their way into becoming the industry’s leading provider in their market space.”
The next generation of VoIP phones are designed for business users looking for rich telephony features, a friendly user-interface and excellent voice quality.
About Yealink
Founded in 2001, Yealink is the Global Top5 SIP Phone Supplier and a leading provider of VoIP Phone and IP communication solutions. Yealink focuses on VoIP products characterized by high cost-performance, easy deployment and affordable price. Based on solid core technology, Yealink benefits customers with its flexibility and broad interoperability with the major IP-PBX, Softswitch and IMS in the market. Chosen by famous carriers, enterprises and clients from over 80 countries, Yealink delivers SMB and diversified customers worldwide with the best choice for extending their value of network communication. More information, please visit: www.yealink.com.
Contacts
Absolute Communications FZE
Marissa Pinto
+971-50-7541420
MarissaP@AbsoluteCommunications.ae
Permalink: http://www.me-newswire.net/news/13724/en
Yealink, globally ranked as the world’s second largest SIP phone provider, have taken another firm step Leading the Gigabit-Ethernet technology revolution with the launch futuristic SIP T29G VoIP Phone. This latest business gadget boast of high-resolution TFT color display for an enriched visual experience while adding Yealink Optima HD voice technology to enable a rich, clear and 3D like voice communication experience through its HD handset and headset.
A successor of the SIP T28P, the SIP T29G builds on the performance of the latter catering to limited budget SME is looking to benefit from the fast speed and convenience of Gigabit Ethernet.
The T29G allows connectivity with multiple devices including EHS headset and USB and encapsulates productivity enhancement features of programmable keys, built-in USB port Bluetooth headset support and accessibility through its USB dongle. SIP T29G also supports expansion modules with a PoE support and enable ease in use by enabling up to 16 VoIP accounts to its users.
Maggie Liu, EMEA Sales Manager of Yealink says, “Yealink’s products are all based on progressive cutting-edge technology that meets rigorous test standards for quality, performance and the lowest-possible power consumption during standby, calls or 3-way conferencing. Our constant strive for excellence drives us to provide a better and refined experience for the end user.”
Sabu Thomas, Director of Channel Development at DVCOM Technology, the distributors of Yealink in the Middle East comments, “Yealink is a world leader in original research and product innovation. While accomplishing the base line solutions and keeping their users interest in the mind, they work their way into becoming the industry’s leading provider in their market space.”
The next generation of VoIP phones are designed for business users looking for rich telephony features, a friendly user-interface and excellent voice quality.
About Yealink
Founded in 2001, Yealink is the Global Top5 SIP Phone Supplier and a leading provider of VoIP Phone and IP communication solutions. Yealink focuses on VoIP products characterized by high cost-performance, easy deployment and affordable price. Based on solid core technology, Yealink benefits customers with its flexibility and broad interoperability with the major IP-PBX, Softswitch and IMS in the market. Chosen by famous carriers, enterprises and clients from over 80 countries, Yealink delivers SMB and diversified customers worldwide with the best choice for extending their value of network communication. More information, please visit: www.yealink.com.
Contacts
Absolute Communications FZE
Marissa Pinto
+971-50-7541420
MarissaP@AbsoluteCommunications.ae
Permalink: http://www.me-newswire.net/news/13724/en
Management Buy out of Synexus Backed by LDC; the Deal Will Enable It to Further Expand Its Global Network
MANCHESTER, England - Tuesday, February 24th 2015 [ME NewsWire]
Synexus has been acquired from Lyceum Capital with the backing of LDC
The deal will enable Synexus to further expand both its global network of clinical research centres - into the US, Asia and South America - and the range of therapy areas it focuses on.
Synexus’, the global leader in its field, contracted order book stands today at a record $216 million.
(BUSINESS WIRE)-- Today (Monday 23rd February 2015) Synexus, the world’s largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centres across the globe, completed a management buyout from Lyceum Capital with the backing of LDC.
LDC is the leading private equity company in the UK mid-market and part of the Lloyds Banking Group.
Commenting on the deal Christophe Berthoux, CEO of Synexus said: “We are delighted to be partnering with LDC. This will give us the firepower to continue expanding our international network and to broaden the number of therapy areas we offer to our pharma and CRO clients.
“We also need to continue to invest in our infrastructure and operations so that we carry on providing clients the best solution delivering thousands of patients and providing excellent quality data.
“We are very grateful to Lyceum. They had the business knowledge and expertise that has helped us transform the company into a professional organisation. The partnership with LDC marks the next phase in our ambitious growth plans.”
Synexus recorded revenues of $63m and profits (EBITDA) of $12m for the financial year ending December 2014, representing a 140 per cent increase in turnover since 2011. Further increases are expected in 2015. Synexus’ contracted order book currently stands at a record $216m an increase of $193m since 2011.
This significant growth has been achieved through a targeted buy-and-build strategy which has included launching new sites and acquiring four businesses since 2007.
Since being taken private in 2007 Synexus has expanded its international network from 13 to 25 dedicated research centres across eight countries. At any one time these centres are involved in more than 200 trials with 14,000 patients. Recent expansion has included new site openings in Hexham in the UK (a pioneering partnership with the NHS), Bochum in Germany, Bucharest in Romania, Poznan in Poland and Sofia in Bulgaria. Synexus also acquired a site near Cape Town in South Africa. This expansion has increased its access to more than 68 million potential patients. In addition it has a network of 25 complementary affiliate sites which further extends Synexus’ reach.
The Synexus model uses its scale to deliver cost advantages and improve speed to market for new compounds. Synexus’ scale also allows it to benefit from its investment in best-in-class quality SOPs, dedicated scientific advisory boards for each therapeutic area and a wide network of KOLs to provide valuable insight to customers. Its specialist tailored enrolment and retention strategies address a key challenge in the global clinical trial industry where almost 90 per cent of all trials undertaken are delayed due to slow patient enrolment resulting in lost sales revenue.
LDC is backing the Synexus management team to realise a clear strategy both through organic growth, using its scale and expertise to continue to take share in what is predominantly a highly fragmented market comprising around 80,000 independent GPs/investigators globally and through the acquisition of a number of potential targets.
The deal was led by LDC Director Ged Gould, who was supported by Investment Directors Simon Braham and Chris Wright. Ged Gould will join the board of Synexus.
Ged Gould, Director and Co-Head of LDC in Manchester, said: “We believe this is a particularly good sector as pharma continues to outsource their development activity. Synexus as the world leader in its field will benefit from this trend as well as the continued growth of the healthcare industry.
"Christophe and the management team have done a fantastic job in building an international network in recent years and we are eager to further support the business break into new markets as it targets opportunities in the US, South America and Asia."
ENDS
Notes to editors:
About Synexus
Synexus® is the world’s largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centres across the globe on behalf of its pharmaceutical, biotech and CRO clients. Synexus operates a global network of 25 dedicated research centres (DRCs) in eight countries– UK, Germany, Poland, South Africa, Romania, Hungary, Bulgaria and Ukraine - focusing on cardiovascular, metabolic (diabetes and obesity), musculo skeletal, respiratory and CNS (dementia and pain) trials mainly in phase III.
About LDC
LDC is the leading private equity company in the UK mid-market. LDC is part of the Lloyds Banking Group and is authorised and regulated by the Financial Conduct Authority. It has completed over 485 investments and has ongoing interests in over 85 businesses in the UK. With a UK regional network, LDC invests up to £100m in MBOs, IBOs and Development Capital transactions in a broad range of sectors including Construction & Property, Financial Services, Healthcare, Industrials, Retail & Consumer, TMT, Travel & Leisure and Support Services. Recent transactions include investments with NEC Group, Waterfall Services, Capital Economics, Eley Group, Adler and Allan, Clifford Thames and Anite Travel.
Contacts
Vane Percy & Roberts
Simon Vane Percy
or
Sarah Roberts
+44 (0) 1737 821890
simon@vanepercy.com
sarah@vanepercy.com
Permalink: http://www.me-newswire.net/news/13750/en
Synexus has been acquired from Lyceum Capital with the backing of LDC
The deal will enable Synexus to further expand both its global network of clinical research centres - into the US, Asia and South America - and the range of therapy areas it focuses on.
Synexus’, the global leader in its field, contracted order book stands today at a record $216 million.
(BUSINESS WIRE)-- Today (Monday 23rd February 2015) Synexus, the world’s largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centres across the globe, completed a management buyout from Lyceum Capital with the backing of LDC.
LDC is the leading private equity company in the UK mid-market and part of the Lloyds Banking Group.
Commenting on the deal Christophe Berthoux, CEO of Synexus said: “We are delighted to be partnering with LDC. This will give us the firepower to continue expanding our international network and to broaden the number of therapy areas we offer to our pharma and CRO clients.
“We also need to continue to invest in our infrastructure and operations so that we carry on providing clients the best solution delivering thousands of patients and providing excellent quality data.
“We are very grateful to Lyceum. They had the business knowledge and expertise that has helped us transform the company into a professional organisation. The partnership with LDC marks the next phase in our ambitious growth plans.”
Synexus recorded revenues of $63m and profits (EBITDA) of $12m for the financial year ending December 2014, representing a 140 per cent increase in turnover since 2011. Further increases are expected in 2015. Synexus’ contracted order book currently stands at a record $216m an increase of $193m since 2011.
This significant growth has been achieved through a targeted buy-and-build strategy which has included launching new sites and acquiring four businesses since 2007.
Since being taken private in 2007 Synexus has expanded its international network from 13 to 25 dedicated research centres across eight countries. At any one time these centres are involved in more than 200 trials with 14,000 patients. Recent expansion has included new site openings in Hexham in the UK (a pioneering partnership with the NHS), Bochum in Germany, Bucharest in Romania, Poznan in Poland and Sofia in Bulgaria. Synexus also acquired a site near Cape Town in South Africa. This expansion has increased its access to more than 68 million potential patients. In addition it has a network of 25 complementary affiliate sites which further extends Synexus’ reach.
The Synexus model uses its scale to deliver cost advantages and improve speed to market for new compounds. Synexus’ scale also allows it to benefit from its investment in best-in-class quality SOPs, dedicated scientific advisory boards for each therapeutic area and a wide network of KOLs to provide valuable insight to customers. Its specialist tailored enrolment and retention strategies address a key challenge in the global clinical trial industry where almost 90 per cent of all trials undertaken are delayed due to slow patient enrolment resulting in lost sales revenue.
LDC is backing the Synexus management team to realise a clear strategy both through organic growth, using its scale and expertise to continue to take share in what is predominantly a highly fragmented market comprising around 80,000 independent GPs/investigators globally and through the acquisition of a number of potential targets.
The deal was led by LDC Director Ged Gould, who was supported by Investment Directors Simon Braham and Chris Wright. Ged Gould will join the board of Synexus.
Ged Gould, Director and Co-Head of LDC in Manchester, said: “We believe this is a particularly good sector as pharma continues to outsource their development activity. Synexus as the world leader in its field will benefit from this trend as well as the continued growth of the healthcare industry.
"Christophe and the management team have done a fantastic job in building an international network in recent years and we are eager to further support the business break into new markets as it targets opportunities in the US, South America and Asia."
ENDS
Notes to editors:
About Synexus
Synexus® is the world’s largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centres across the globe on behalf of its pharmaceutical, biotech and CRO clients. Synexus operates a global network of 25 dedicated research centres (DRCs) in eight countries– UK, Germany, Poland, South Africa, Romania, Hungary, Bulgaria and Ukraine - focusing on cardiovascular, metabolic (diabetes and obesity), musculo skeletal, respiratory and CNS (dementia and pain) trials mainly in phase III.
About LDC
LDC is the leading private equity company in the UK mid-market. LDC is part of the Lloyds Banking Group and is authorised and regulated by the Financial Conduct Authority. It has completed over 485 investments and has ongoing interests in over 85 businesses in the UK. With a UK regional network, LDC invests up to £100m in MBOs, IBOs and Development Capital transactions in a broad range of sectors including Construction & Property, Financial Services, Healthcare, Industrials, Retail & Consumer, TMT, Travel & Leisure and Support Services. Recent transactions include investments with NEC Group, Waterfall Services, Capital Economics, Eley Group, Adler and Allan, Clifford Thames and Anite Travel.
Contacts
Vane Percy & Roberts
Simon Vane Percy
or
Sarah Roberts
+44 (0) 1737 821890
simon@vanepercy.com
sarah@vanepercy.com
Permalink: http://www.me-newswire.net/news/13750/en
Subscribe to:
Posts (Atom)